06/06/2025 - FAU
FAU Amyloidosis Project
A FairfaxWood Health & Innovation Technology Initiative
About Amyloidosis
Amyloid proteins cause life-threatening diseases that can be present throughout the body, including the heart, kidneys, liver and brain. The most common localized form of amyloidosis is in the brain. Cerebral amyloidosis, when symptomatic, usually manifests in one of two ways: in Alzheimer's disease and related dementias and in stroke. Treatments are very limited and there are no cures. Because amyloid does not affect just one organ, unraveling the underlying cause of amyloid fibril creation – a hallmark of this disease – is complex and challenging. Florida Atlantic University's Charles E. Schmidt College of Medicine has started an important and timely conversation to bridge the gap between amyloid research and clinical practice.
Amyloidosis in the News
07/18/2024 - WLRN-NPR
05/17/2024 - FAU
08/09/2023 - Palm Beach Post
07/18/2023 - Sun Sentinel
07/14/2023 - Forbes
07/13/2023 - South Florida Hospital News and Healthcare Report
07/13/2023 - South Florida Business Journal
07/13/2023 - FAU
07/13/2023 - Florida Atlantic University Foundation, Inc.
Research
Amyloidosis and Amyloid-Related Diseases: Political Contexts of Early Discoveries
Turtz M, Bone BM, Ramos A, Dobbs M. Amyloidosis and Amyloid-Related Diseases: Political Contexts of Early Discoveries. Academic Medicine & Surgery. Published online October 10, 2025. doi:10.62186/001c.144699
A Punctuated Equilibrium Analysis of Amyloidosis (and Amyloid Related Diseases) in U.S. Policy Making
Turtz M, Dobbs M. A Punctuated Equilibrium Analysis of Amyloidosis (and Amyloid Related Diseases) in U.S. Policy Making. Academic Medicine & Surgery. Published online April 19, 2025. doi:10.62186/001c.136963
Upcoming Events
May 2026
3rd Annual Amyloid Related Diseases Summit
Connect with leading experts at FAU's Annual Amyloid Related Diseases Summit, where groundbreaking research and innovative treatments for amyloid-related diseases are showcased. This event bridges the gap between research and clinical practice, fostering collaboration to combat conditions like Alzheimer’s, stroke, and organ-related amyloidosis. Be part of the progress shaping the future of amyloid disease care.